Motilal Oswal
15 February 2019 volume growth was 9.6% YoY. EBITDA increased 14.9% YoY to INR2.4b (our category saw revenue growth of 7.5% YoY. stood at 43% (-110bp YoY, -30bp QoQ) while value market share for Boost stood at 10.8% (-50bp YoY, -10bp QoQ). Higher staff costs (+140bp YoY to 14%) and ad spends (+110bp YoY to 12.1%) were almost entirely offset by lower other expenses (-220bp YoY to 23.
More from GlaxoSmithKline Consumer Healthcare Ltd.
Recommended